NCT03661047 2021-11-17
OMICC
Massachusetts General Hospital
Phase 2 Withdrawn
Clinical Trials
10 trialsNCT01869764 2019-10-30
Omega-3 Fatty Acid in Treating Patients With Stage I-III Breast Cancer
Wake Forest University Health Sciences
Phase 2 Completed
NCT02795572 2019-07-05
CIPN
AHS Cancer Control Alberta
Phase 2 Terminated
NCT03936621 2019-05-07
Omega
British Columbia Cancer Agency
Phase 2 Unknown
NCT02150525 2018-08-09
Effect of Omega 3 on Atrophic Vaginitis in Breast Cancer Survivors
Ohio State University Comprehensive Cancer Center
Phase 2 Completed
NCT01051154 2016-08-22
DHA-ALL
Coordinación de Investigación en Salud, Mexico
Phase 2 Completed
NCT02373579 2015-02-27
Effect of Omega-3 Fatty Acids on Methotrexate Induced Hepatotoxicity in Children With Acute Lymphoblastic Leukemia
Ain Shams University
Phase 2 Completed
NCT00930527 2014-07-23
Omega-3-Fatty Acid on Joint Symptoms Inducted by Aromatase Inhibitors
Columbia University
Phase 2 Terminated
NCT00899353 2013-12-12
Prevention of Disease Progression in Early Stage Indolent B Cell Malignancies. (SMM)
Marshall University
Phase 2 Terminated
NCT00455416 2008-05-21
KLYMF
Oslo University Hospital
Phase 2 Unknown